Category: Dispensaries
-
Nova Cannabis (NOVC.T) and Legal Cannabis in Canada, is the worst behind us?
The road for Canadian legal cannabis operators has been littered with hardship since the industry took a header in 2019. Restrictive regulations, combined with bad business practices in a saturated market produced a blood bath of bankruptcy that caused investors to run for the hills. With little available capital and a staggering over capacity, private…
-
Cannabis memory lane: Who’s sticking it out, who’s dead and dying
I was feeling every ounce of my chest cold, the thing everyone apparently has, the one that’s going around, the one that’s not covid but who could tell. I was also standing on a stage at the Richmond Chamber of Commerce awards gala, blinking at stage lights and peaking over the shoulders of some very…
-
Tipping the Scale: Navigating the Turbulent Waters of the Canadian Legal Cannabis Market
The legal cannabis industry in Canada, still in its infancy nearly five years post-legalization, is traversing a tumultuous terrain. As the initial euphoria fades, the market is grappling with mounting challenges. These include the continuous race to the bottom with pot prices, the persistent prevalence of the illicit market, and the looming uncertainties in the…
-
Canada’s Legal Cannabis Market: Progress, Challenges, and the Future
The legalization of the cannabis market in Canada marked a significant milestone in the country’s history. Four years after this groundbreaking event, the retail market has experienced remarkable growth, with a 122.3% annual increase in per capita stores and a 91.7% annual increase in per capita sales. There are now 3,305 cannabis stores across the…
-
If I had a billion dollars: the cannabis edition, Chris Parry’s Infamous Dad Talk, Hexo (HEXO.T), GrowGeneration (GRWG.NASDAQ), Sundial (SNDL.NASDAQ)
In early 2018, Equity Guru had 30 cannabis clients. At the time, it was our specialty, our niche. Equity Guru owner Chris Parry was the one of the first journalists to take the sector seriously. Later, we signed a bioscience accelerator (XPhyto Therapeutics (XPHY.C), a concealed weapon detector co. (Patriot One (PAT.T) and a grocery…
-
Harborside (HBOR.C) receives approval for retail sales at San Leandro dispensary
Harborside (HBOR.C) announced it has received approval from the California Bureau of Cannabis Control to begin retail sales at San Leandro Wellness Solutions (SLWS) dispensary. This approval allows them to move forward with their previously announced plans for SLWS, when they decided to transition from a medical use to an adult-use dispensary. As they previously…
-
Harborside (HBOR.C) books 2020 revenues of $63 million – 130% of its market cap
Harborside’s full year 2020 gross revenues expanded 29% year-over-year to $63.4 million.
-
Harborside (HBOR.C) invests $5-million in Loudpack – a CA cultivator with a deep portfolio of branded products
Loudpack is a California cannabis company with “a broad cultivation, manufacturing, processing, and distribution footprint and a strong portfolio of brands”.
-
Harborside (HBOR.C) raises $20 million, narrows focus on California, projects 2021 cannabis revenues equal to its current market cap
The January 20, 2021 press release declared that HBOR is “expecting gross revenues in line with previously issued guidance of approximately $61 – 63 million, and positive EBITDA”.
-
Harborside (HBOR.C) buys another California dispensary
With HBOR’s track record of revenue-growth-per-location, the addition of FGW is likely to accelerate revenue growth.